Cargando…
Vaginal micronized progesterone capsule versus vaginal progesterone gel for lutheal support in normoresponder IVF/ICSI-ET cycles
OBJECTIVE: To compare the outcomes of luteal phase support by micronized progesteron vaginal capsule 600mg/day and progesterone vaginal gel 180mg/day in the normoresponder IVF/ICSI-ET cycles of the patients down-regulated via GnRH agonist long protocol or fixed antagonist protocol below 40 years of...
Autores principales: | Sofuoglu, Kenan, Gun, Ismet, Sahin, Sadik, Ozden, Okan, Tosun, Oktay, Eroglu, Mustafa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Professional Medical Publications
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4476333/ https://www.ncbi.nlm.nih.gov/pubmed/26101482 http://dx.doi.org/10.12669/pjms.312.6613 |
Ejemplares similares
-
Comparing intramuscular progesterone, vaginal progesterone and 17 -hydroxyprogestrone caproate in IVF and ICSI cycle
por: Moini, Ashraf, et al.
Publicado: (2011) -
Oral versus Vaginal Micronized Progesterone for the Treatment of Threatened Miscarriage
por: Parveen, Rashida, et al.
Publicado: (2021) -
Adding Weekly Intramuscular Progesterone to a Twice Daily Vaginal Progesterone Capsule for Luteal Phase Support in IVF/ICSI Cycles Results in Similar Live Birth Rates
por: Gari, Salwa, et al.
Publicado: (2022) -
Clinical Re-evaluation on Bioequivalence and Relative Bioavailability of Micronized Progesterone Hard Capsule (Yimaxin) and Micronized Progesterone Soft Capsule (Utrogestan) under Vaginal and Oral Administration Routes
por: Wang, Hanbi, et al.
Publicado: (2021) -
Comparison of conventional IVF versus ICSI in non-male factor, normoresponder patients
por: Eftekhar, Maryam, et al.
Publicado: (2012)